
Inferior Vena Cava Filters Market Report 2026
Global Outlook – By Product (Retrievable Inferior Vena Cava (IVC) Filters, Permanent Inferior Vena Cava (IVC) Filters), By Material (Non-Ferromagnetic Materials, Ferromagnetic Materials), By Application (Treatment Of Venous Thromboembolism (VTE), Prevention Of Pulmonary Embolism (PE), Other Applications), By End User (Hospitals, Ambulatory Surgical Centers, Other End Users) – Market Size, Trends, Strategies, and Forecast to 2035
Inferior Vena Cava Filters Market Overview
• Inferior Vena Cava Filters market size has reached to $5.79 billion in 2025 • Expected to grow to $8.87 billion in 2030 at a compound annual growth rate (CAGR) of 9% • Growth Driver: The Growing Preference for Minimally Invasive Procedures Fueling the Growth of the Market Due to Increasing Demand for Less Disruptive Interventions • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Inferior Vena Cava Filters Market?
An inferior vena cava filter refers to a small device that stops blood clots from going into the lungs through the inferior vena cava, a large vein in the body. The inferior vena cava brings deoxygenated blood back to the heart and lungs and the inferior vena cava filter catches any blood clots that pass through them before it could reach the heart or lungs. The main product types of inferior vena cava filters are retrievable inferior vena cava (IVC) filters and permanent inferior vena cava (IVC) filters. Retrievable inferior vena cava filters are filters that permit percutaneous removal when the risk of blood clot resolves. The various materials include non-ferromagnetic materials and ferromagnetic materials. These are used in various applications such as the treatment of venous thromboembolism (VTE), prevention of pulmonary embolism (pe), and others and used by hospitals, ambulatory surgical centers, and others.
What Is The Inferior Vena Cava Filters Market Size and Share 2026?
The inferior vena cava filters market size has grown strongly in recent years. It will grow from $5.79 billion in 2025 to $6.29 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to increasing incidence of venous thromboembolism, growth in surgical interventions, rising use of interventional radiology procedures, expansion of hospital-based vascular care, increased awareness of pulmonary embolism risks.What Is The Inferior Vena Cava Filters Market Growth Forecast?
The inferior vena cava filters market size is expected to see strong growth in the next few years. It will grow to $8.87 billion in 2030 at a compound annual growth rate (CAGR) of 9.0%. The growth in the forecast period can be attributed to increasing demand for advanced retrievable filters, rising focus on post-implantation monitoring, expansion of minimally invasive treatment adoption, growing elderly population with clotting risks, technological improvements in filter design. Major trends in the forecast period include increasing adoption of retrievable ivc filters, rising use of non-ferromagnetic materials, growing preference for minimally invasive implantation techniques, expansion of temporary filter applications, enhanced focus on patient safety and retrieval rates.Global Inferior Vena Cava Filters Market Segmentation
1) By Product: Retrievable Inferior Vena Cava (IVC) Filters, Permanent Inferior Vena Cava (IVC) Filters 2) By Material: Non-Ferromagnetic Materials, Ferromagnetic Materials 3) By Application: Treatment Of Venous Thromboembolism (VTE), Prevention Of Pulmonary Embolism (PE), Other Applications 4) By End User: Hospitals, Ambulatory Surgical Centers, Other End Users Subsegments: 1) By Retrievable IVC Filters: Optional Retrievable Filters, Temporary Filters 2) By Permanent IVC Filters: Stainless Steel Filters, Titanium FiltersWhat Are The Drivers Of The Inferior Vena Cava Filters Market?
The growing preference for non-invasive or minimally invasive procedures is expected to propel the growth of the inferior vena cava filter market going forward. Minimally invasive procedures refer to medical interventions that reduce disruption to normal anatomical structures and shorten recovery time. The rise in minimally invasive procedures results from patients and clinicians seeking safer, faster, and less painful treatment options. Inferior vena cava filters support this preference by offering a minimally invasive method to prevent blood-clot complications in individuals at risk of deep vein thrombosis or pulmonary embolism. For instance, in June 2025, according to the American Society of Plastic Surgeons, a US-based professional society, minimally invasive cosmetic procedures reached 28.5 million in 2024, rising by 3% compared to 2023, with neuromodulator injections alone totaling 9.9 million procedures. Therefore, the growing preference for non-invasive or minimally invasive procedures is driving the growth of the inferior vena cava filter industry. The rise in surgical procedures is expected to propel the growth of the inferior vena cava (IVC) filters market going forward. Surgical procedures refer to medical operations aimed at diagnosing, treating, and preventing health issues through physical modifications to tissues and organs. The increase in surgical procedures is primarily attributed to technological advancements in medicine, an expanding elderly demographic, and a higher incidence of chronic health conditions. The surge in surgical procedures boosts the inferior vena cava (IVC) filters market by driving the need for these devices, which are essential for preventing blood clots during and following surgical operations. For instance, in September 2023, according to the data from the American Society of Plastic Surgeons (ASPS), a US-based non-profit organization, estimated that the total number of cosmetic surgery procedures increased to 1,575,244 in 2023, marking a 5% rise compared to 1,498,361 procedures in 2022. Therefore, the rise in surgical procedures is driving the inferior vena cava (IVC) filters market.Key Players In The Global Inferior Vena Cava Filters Market
Major companies operating in the inferior vena cava filters market are B. Braun Melsungen AG, Boston Scientific Corporation, Cook Medical LLC, Medtronic plc, Teleflex Incorporated, Merit Medical Systems Inc., Argon Medical Devices Inc., Lifetech Scientific Corporation, Cordis Corporation, Becton Dickinson and Company, C. R. Bard Inc., Penumbra Inc., Terumo Corporation, Getinge AB, Philips Healthcare, Abbott Laboratories, AngioDynamics Inc., Endologix LLC, MicroPort Scientific Corporation, Stryker CorporationWhat Are Latest Mergers And Acquisitions In The Inferior Vena Cava Filters Market?
In September 2024, Merit Medical Systems Inc., a US-based healthcare-technology company, acquired Cook Medical’s lead management portfolio for approximately $210 million. With this acquisition, Merit aimed to strengthen its electrophysiology and cardiac rhythm management (CRM) business by adding a differentiated, end-to-end lead management product line. Cook Medical is a US-based medical device manufacturer that provides inferior vena cava (IVC) filters.Regional Outlook
North America was the largest region in the inferior vena cava filters market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, SpainWhat Defines the Inferior Vena Cava Filters Market?
The inferior vena cava filters market consists of sales of resorbable IVC filters, Polydioxanone (PPDO) IVC filters. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.Inferior Vena Cava Filters Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $6.29 billion |
| Revenue Forecast In 2035 | $8.87 billion |
| Growth Rate | CAGR of 8.7% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Product, Material, Application, End User |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | B. Braun Melsungen AG, Boston Scientific Corporation, Cook Medical LLC, Medtronic plc, Teleflex Incorporated, Merit Medical Systems Inc., Argon Medical Devices Inc., Lifetech Scientific Corporation, Cordis Corporation, Becton Dickinson and Company, C. R. Bard Inc., Penumbra Inc., Terumo Corporation, Getinge AB, Philips Healthcare, Abbott Laboratories, AngioDynamics Inc., Endologix LLC, MicroPort Scientific Corporation, Stryker Corporation |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
